IVBXF · Innovent Biologics Inc/ADR · Analyst Estimates
Market Cap
$20.93B
Shares
1.74B
Analyst Estimates
Compare analyst forecasts for Innovent Biologics Inc/ADR across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 15:33 UTC · Publication dates shown per estimate · 4 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
CNY
Publication date not stated |
17155000000
|
18553399830
|
19800000000
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
28
|
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
CNY
Publication date not stated |
19337000000
|
22993513880
|
26105371000
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
30
|